DoW Melanoma Research Program Idea Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The FY26 Melanoma Research Program Idea Award is designed to support innovative and exploratory research projects that involve high-risk but potentially high-reward concepts in melanoma research. Proposals should emphasize novelty and creativity, and the goal by the end of the funding period is to generate proof of principle and preliminary data sufficient to enable pursuit of subsequent funding. Notably, submitting preliminary data with the application is discouraged, and only investigators who receive an invitation following a required pre-application will be permitted to submit a full application. The program is funded by the Congressionally Directed Medical Research Programs with an expected total allocation of approximately $5.6 million, intended to support around 10 awards. Each award can provide up to $560,000 in total costs over a maximum period of two years. Funding is anticipated to come from FY26 appropriations, which will remain available for use until September 30, 2032, with awards being made no later than September 30, 2027. The Department of the Army, under the Department of Defense, administers this program, and inquiries can be directed to the eBRAP Help Desk.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Idea Award supports innovative, exploratory, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding.
Distinctive Features:
· Preliminary data are discouraged.
· After submitting the required pre-application, investigators must receive an invitation to submit a full application.
Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $5.6M to fund approximately 10 Idea Award applications with total cost caps of $0.56M per award. The maximum period of performance is 2 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
https://cdmrp.health.mil/pubs/press/2026/mrppreann
